HEADER HYDROLASE/INHIBITOR 11-JUL-11 3SU6 TITLE CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH TITLE 2 VANIPREVIR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NS3 PROTEASE, NS4A PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NS4A (UNP RESIDUES 1674-1688), NS3 (UNP RESIDUES 1027- COMPND 5 1208); COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 31646; SOURCE 4 STRAIN: SUBTYPE 1A, BID-V318; SOURCE 5 GENE: NS3-NS4A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS DRUG RESISTANCE, DRUG DESIGN, PROTEASE INHIBITORS, SERINE PROTEASE, KEYWDS 2 VIRAL PROTEIN, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.A.SCHIFFER,K.P.ROMANO REVDAT 4 28-FEB-24 3SU6 1 REMARK SEQADV HETSYN LINK REVDAT 3 08-NOV-17 3SU6 1 REMARK REVDAT 2 23-AUG-17 3SU6 1 SOURCE REMARK REVDAT 1 05-SEP-12 3SU6 0 JRNL AUTH K.P.ROMANO,A.ALI,C.AYDIN,D.SOUMANA,A.OZEN,L.M.DEVEAU, JRNL AUTH 2 C.SILVER,H.CAO,A.NEWTON,C.J.PETROPOULOS,W.HUANG,C.A.SCHIFFER JRNL TITL THE MOLECULAR BASIS OF DRUG RESISTANCE AGAINST HEPATITIS C JRNL TITL 2 VIRUS NS3/4A PROTEASE INHIBITORS. JRNL REF PLOS PATHOG. V. 8 02832 2012 JRNL REFN ISSN 1553-7366 JRNL PMID 22910833 JRNL DOI 10.1371/JOURNAL.PPAT.1002832 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 76063 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.151 REMARK 3 R VALUE (WORKING SET) : 0.150 REMARK 3 FREE R VALUE : 0.165 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3827 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.13 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4095 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE SET COUNT : 230 REMARK 3 BIN FREE R VALUE : 0.2470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1422 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 194 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.53000 REMARK 3 B22 (A**2) : -0.22000 REMARK 3 B33 (A**2) : -0.32000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.029 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.017 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.756 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.971 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.969 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1572 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1020 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2164 ; 1.363 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2456 ; 0.779 ; 3.006 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 212 ; 6.464 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 51 ;35.736 ;22.941 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 229 ;11.251 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;14.028 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 254 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1756 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 297 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1013 ; 1.055 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 418 ; 0.269 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1634 ; 1.748 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 559 ; 2.441 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 518 ; 3.655 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2592 ; 0.854 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 3SU6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-AUG-11. REMARK 100 THE DEPOSITION ID IS D_1000066655. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 76300 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.32300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-25% PEG 3350, 0.1M MES (PH 6.5), 4% REMARK 280 AMMONIUM SULFATE, HANGING DROP, VAPOR DIFFUSION, TEMPERATURE REMARK 280 295K, PH 6.2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.49050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.91450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.22550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 29.91450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.49050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.22550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 980 REMARK 465 ARG A 1180 REMARK 465 SER A 1181 REMARK 465 PRO A 1182 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 987 CG CD CE NZ REMARK 470 LYS A 988 CG CD CE NZ REMARK 470 ASP A1003 CG OD1 OD2 REMARK 470 GLU A1013 CG CD OE1 OE2 REMARK 470 GLU A1014 CG CD OE1 OE2 REMARK 470 GLU A1018 CG CD OE1 OE2 REMARK 470 ARG A1024 CG CD NE CZ NH1 NH2 REMARK 470 GLN A1028 CG CD OE1 NE2 REMARK 470 ARG A1092 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1130 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1161 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1165 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1043 -165.57 -164.08 REMARK 500 ARG A1155 -53.26 -121.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 VANIPREVIR (MK-7009) IS A MACROCYCLIC, PEPTIDOMIMETIC HCV NS3/4A REMARK 600 PROTEASE INHIBITOR FROM MERCK. THE DRUG MIMICS THE PEPTIDE BACKBONE REMARK 600 OF PROTEINS, ALTHOUGH THE DRUG MOIETIES CANNOT BE SEQUENCED USING REMARK 600 AMINO ACID NOMENCLATURE. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 5 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1097 SG REMARK 620 2 CYS A1099 SG 107.3 REMARK 620 3 CYS A1145 SG 109.5 118.4 REMARK 620 4 HIS A1149 ND1 123.6 100.5 98.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SU3 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SU3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE IN COMPLEX WITH VANIPREVIR REMARK 900 RELATED ID: 3SU4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH REMARK 900 VANIPREVIR REMARK 900 RELATED ID: 3SU5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH REMARK 900 VANIPREVIR REMARK 900 RELATED ID: 3SUD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE IN COMPLEX WITH MK-5172 REMARK 900 RELATED ID: 3SUE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH REMARK 900 MK-5172 REMARK 900 RELATED ID: 3SUF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH REMARK 900 MK-5172 REMARK 900 RELATED ID: 3SUG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH REMARK 900 MK-5172 REMARK 900 RELATED ID: 3SV6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE IN COMPLEX WITH TELAPREVIR REMARK 900 RELATED ID: 3SV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH REMARK 900 TELAPREVIR REMARK 900 RELATED ID: 3SV8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH REMARK 900 TELAPREVIR REMARK 900 RELATED ID: 3SV9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH REMARK 900 TELAPREVIR REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE COFACTOR 4A RESIDUES 990-1000 (GLY SER VAL VAL ILE VAL GLY ARG REMARK 999 ILE ASN LEU) IN THIS ENTRY CORRESPOND TO RESIDUES NUMBERING 1678- REMARK 999 1688 OF DATABASE SEQUENCE REFERENCE (UNP A8DG50). THIS PEPTIDE IS REMARK 999 COVALENTLY LINKED TO THE N-TERMINUS OF NS3. C1679S MUTATION WAS REMARK 999 ENGINEERED TO PREVENT DISULFIDE FORMATION. THE V1686I AND I1687N REMARK 999 WERE ENGINEERED TO OPTIMIZE THE LINKER BETWEEN THE COFACTOR 4A AND REMARK 999 NS3. DBREF 3SU6 A 986 1000 UNP A8DG50 A8DG50_9HEPC 1674 1688 DBREF 3SU6 A 1001 1182 UNP A8DG50 A8DG50_9HEPC 1027 1208 SEQADV 3SU6 GLY A 980 UNP A8DG50 EXPRESSION TAG SEQADV 3SU6 SER A 981 UNP A8DG50 EXPRESSION TAG SEQADV 3SU6 HIS A 982 UNP A8DG50 EXPRESSION TAG SEQADV 3SU6 MET A 983 UNP A8DG50 EXPRESSION TAG SEQADV 3SU6 ALA A 984 UNP A8DG50 EXPRESSION TAG SEQADV 3SU6 SER A 985 UNP A8DG50 EXPRESSION TAG SEQADV 3SU6 MET A 986 UNP A8DG50 CYS 1674 ENGINEERED MUTATION SEQADV 3SU6 LYS A 987 UNP A8DG50 LEU 1675 ENGINEERED MUTATION SEQADV 3SU6 LYS A 988 UNP A8DG50 SER 1676 ENGINEERED MUTATION SEQADV 3SU6 LYS A 989 UNP A8DG50 THR 1677 ENGINEERED MUTATION SEQADV 3SU6 SER A 991 UNP A8DG50 CYS 1679 SEE REMARK 999 SEQADV 3SU6 ILE A 998 UNP A8DG50 VAL 1686 SEE REMARK 999 SEQADV 3SU6 ASN A 999 UNP A8DG50 ILE 1687 SEE REMARK 999 SEQADV 3SU6 SER A 1001 UNP A8DG50 ALA 1027 ENGINEERED MUTATION SEQADV 3SU6 GLY A 1002 UNP A8DG50 PRO 1028 ENGINEERED MUTATION SEQADV 3SU6 ASP A 1003 UNP A8DG50 ILE 1029 ENGINEERED MUTATION SEQADV 3SU6 GLU A 1013 UNP A8DG50 LEU 1039 ENGINEERED MUTATION SEQADV 3SU6 GLU A 1014 UNP A8DG50 LEU 1040 ENGINEERED MUTATION SEQADV 3SU6 GLN A 1017 UNP A8DG50 ILE 1043 ENGINEERED MUTATION SEQADV 3SU6 GLU A 1018 UNP A8DG50 ILE 1044 ENGINEERED MUTATION SEQADV 3SU6 GLN A 1021 UNP A8DG50 LEU 1047 ENGINEERED MUTATION SEQADV 3SU6 THR A 1040 UNP A8DG50 ALA 1066 ENGINEERED MUTATION SEQADV 3SU6 SER A 1047 UNP A8DG50 CYS 1073 ENGINEERED MUTATION SEQADV 3SU6 LEU A 1052 UNP A8DG50 CYS 1078 ENGINEERED MUTATION SEQADV 3SU6 THR A 1072 UNP A8DG50 ILE 1098 ENGINEERED MUTATION SEQADV 3SU6 GLN A 1086 UNP A8DG50 PRO 1112 ENGINEERED MUTATION SEQADV 3SU6 ALA A 1139 UNP A8DG50 SER 1165 ENGINEERED MUTATION SEQADV 3SU6 THR A 1156 UNP A8DG50 ALA 1182 ENGINEERED MUTATION SEQADV 3SU6 SER A 1159 UNP A8DG50 CYS 1185 ENGINEERED MUTATION SEQRES 1 A 203 GLY SER HIS MET ALA SER MET LYS LYS LYS GLY SER VAL SEQRES 2 A 203 VAL ILE VAL GLY ARG ILE ASN LEU SER GLY ASP THR ALA SEQRES 3 A 203 TYR ALA GLN GLN THR ARG GLY GLU GLU GLY CYS GLN GLU SEQRES 4 A 203 THR SER GLN THR GLY ARG ASP LYS ASN GLN VAL GLU GLY SEQRES 5 A 203 GLU VAL GLN ILE VAL SER THR ALA THR GLN THR PHE LEU SEQRES 6 A 203 ALA THR SER ILE ASN GLY VAL LEU TRP THR VAL TYR HIS SEQRES 7 A 203 GLY ALA GLY THR ARG THR ILE ALA SER PRO LYS GLY PRO SEQRES 8 A 203 VAL THR GLN MET TYR THR ASN VAL ASP LYS ASP LEU VAL SEQRES 9 A 203 GLY TRP GLN ALA PRO GLN GLY SER ARG SER LEU THR PRO SEQRES 10 A 203 CYS THR CYS GLY SER SER ASP LEU TYR LEU VAL THR ARG SEQRES 11 A 203 HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG GLY ASP SER SEQRES 12 A 203 ARG GLY SER LEU LEU SER PRO ARG PRO ILE SER TYR LEU SEQRES 13 A 203 LYS GLY SER ALA GLY GLY PRO LEU LEU CYS PRO ALA GLY SEQRES 14 A 203 HIS ALA VAL GLY ILE PHE ARG THR ALA VAL SER THR ARG SEQRES 15 A 203 GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO VAL GLU SER SEQRES 16 A 203 LEU GLU THR THR MET ARG SER PRO HET SU3 A 1 53 HET GOL A 3 6 HET SO4 A 2 5 HET SO4 A 4 5 HET ZN A 5 1 HETNAM SU3 (5R,7S,10S)-10-TERT-BUTYL-N-{(1R,2R)-1- HETNAM 2 SU3 [(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHYLCYCLOPROPYL}- HETNAM 3 SU3 15,15-DIMETHYL-3,9,12-TRIOXO-6,7,9,10,11,12,14,15,16, HETNAM 4 SU3 17,18,19-DODECAHYDRO-1H,5H-2,23:5,8-DIMETHANO-4,13,2, HETNAM 5 SU3 8,11-BENZODIOXATRIAZACYCLOHENICOSINE-7(3H)-CARBOXAMIDE HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM ZN ZINC ION HETSYN SU3 VANIPREVIR; MK-7009 HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 SU3 C38 H55 N5 O9 S FORMUL 3 GOL C3 H8 O3 FORMUL 4 SO4 2(O4 S 2-) FORMUL 6 ZN ZN 2+ FORMUL 7 HOH *194(H2 O) HELIX 1 1 HIS A 982 MET A 986 5 5 HELIX 2 2 GLY A 1012 GLY A 1023 1 12 HELIX 3 3 TYR A 1056 GLY A 1060 1 5 HELIX 4 4 SER A 1133 LEU A 1135 5 3 HELIX 5 5 VAL A 1172 MET A 1179 1 8 SHEET 1 A 7 TYR A1006 GLN A1009 0 SHEET 2 A 7 VAL A 993 ASN A 999 -1 N ASN A 999 O TYR A1006 SHEET 3 A 7 VAL A1033 SER A1037 -1 O ILE A1035 N VAL A 995 SHEET 4 A 7 THR A1042 ILE A1048 -1 O ALA A1045 N GLN A1034 SHEET 5 A 7 VAL A1051 VAL A1055 -1 O TRP A1053 N THR A1046 SHEET 6 A 7 LEU A1082 GLN A1086 -1 O TRP A1085 N LEU A1052 SHEET 7 A 7 TYR A1075 ASN A1077 -1 N ASN A1077 O LEU A1082 SHEET 1 B 7 ASP A1103 VAL A1107 0 SHEET 2 B 7 VAL A1113 ARG A1118 -1 O ILE A1114 N LEU A1106 SHEET 3 B 7 ARG A1123 PRO A1131 -1 O SER A1125 N ARG A1117 SHEET 4 B 7 VAL A1163 PRO A1171 -1 O ALA A1164 N ARG A1130 SHEET 5 B 7 ALA A1150 THR A1160 -1 N THR A1156 O ASP A1168 SHEET 6 B 7 PRO A1142 LEU A1144 -1 N LEU A1143 O VAL A1151 SHEET 7 B 7 ASP A1103 VAL A1107 -1 N TYR A1105 O LEU A1144 LINK ZN ZN A 5 SG CYS A1097 1555 1555 2.36 LINK ZN ZN A 5 SG CYS A1099 1555 1555 2.31 LINK ZN ZN A 5 SG CYS A1145 1555 1555 2.34 LINK ZN ZN A 5 ND1 HIS A1149 1555 1555 2.10 SITE 1 AC1 23 HOH A 33 HOH A 56 HOH A 99 HOH A 106 SITE 2 AC1 23 HOH A 119 HOH A 121 HOH A 142 HIS A 982 SITE 3 AC1 23 GLN A1041 PHE A1043 HIS A1057 GLY A1058 SITE 4 AC1 23 ASP A1079 ASP A1081 LEU A1135 LYS A1136 SITE 5 AC1 23 GLY A1137 SER A1138 ALA A1139 PHE A1154 SITE 6 AC1 23 ARG A1155 THR A1156 ALA A1157 SITE 1 AC2 6 HOH A 43 HOH A 51 HOH A 88 HOH A 92 SITE 2 AC2 6 ARG A1109 HIS A1110 SITE 1 AC3 6 HOH A 137 HOH A 194 ASN A1049 GLY A1050 SITE 2 AC3 6 ASP A1121 SER A1122 SITE 1 AC4 8 HOH A 20 HOH A 26 HOH A 29 HOH A 135 SITE 2 AC4 8 HOH A 197 TYR A1006 GLN A1008 TYR A1056 SITE 1 AC5 4 CYS A1097 CYS A1099 CYS A1145 HIS A1149 CRYST1 54.981 58.451 59.829 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018188 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017108 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016714 0.00000